Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Annals of Clinical and Translational Neurology
|
September 12, 2025
Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data
Ian W McKeague, Kristin Engelstad, Yue Ge, et al.
Journal of Inherited Metabolic Disease
|
December 28, 2020
Regulatory environment for novel therapeutic development in mitochondrial diseases
Michio Hirano, Andres Berardo, Emanuele Barca, et al.
ESC Heart Failure
|
December 30, 2020
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
Kenji Matsumoto, Yi Xiao, Shunichi Homma, et al.
ESC Heart Failure
|
September 21, 2021
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trial
Kazato Ito, Siyuan Li, Shunichi Homma, et al.
Therapeutic Advances in Rare Disease
|
March 6, 2024
A United States-based patient-reported adult polyglucosan body disease registry: initial results
Jacy Sparks, Francesco Michelassi, John L P Thompson, et al.
Human Reproduction (Oxford, England)
|
March 4, 2016
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy
Kristin Engelstad, Miriam Sklerov, Joshua Kriger, et al.
Internal and Emergency Medicine
|
February 23, 2024
Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial
Giulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
March 17, 2007
Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial
Petra Kaufmann, Gilbero Levy, Jacquelina Montes, et al.
European Journal of Clinical Investigation
|
November 18, 2024
Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post-hoc analysis of the WARCEF trial
Hironori Ishiguchi, Yang Chen, Bi Huang, et al.
Journal of Translational Genetics and Genomics
|
July 1, 2020
The North American mitochondrial disease registry
Xiomara Q Rosales, John L P Thompson, Richard Haas, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Annals of Clinical and Translational Neurology
|
September 12, 2025
Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data
Ian W McKeague, Kristin Engelstad, Yue Ge, et al.
Journal of Inherited Metabolic Disease
|
December 28, 2020
Regulatory environment for novel therapeutic development in mitochondrial diseases
Michio Hirano, Andres Berardo, Emanuele Barca, et al.
ESC Heart Failure
|
December 30, 2020
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
Kenji Matsumoto, Yi Xiao, Shunichi Homma, et al.
ESC Heart Failure
|
September 21, 2021
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trial
Kazato Ito, Siyuan Li, Shunichi Homma, et al.
Therapeutic Advances in Rare Disease
|
March 6, 2024
A United States-based patient-reported adult polyglucosan body disease registry: initial results
Jacy Sparks, Francesco Michelassi, John L P Thompson, et al.
Human Reproduction (Oxford, England)
|
March 4, 2016
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy
Kristin Engelstad, Miriam Sklerov, Joshua Kriger, et al.
Internal and Emergency Medicine
|
February 23, 2024
Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial
Giulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
March 17, 2007
Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial
Petra Kaufmann, Gilbero Levy, Jacquelina Montes, et al.
European Journal of Clinical Investigation
|
November 18, 2024
Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post-hoc analysis of the WARCEF trial
Hironori Ishiguchi, Yang Chen, Bi Huang, et al.
Journal of Translational Genetics and Genomics
|
July 1, 2020
The North American mitochondrial disease registry
Xiomara Q Rosales, John L P Thompson, Richard Haas, et al.
Page
of 6